Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2024
2 years of board service in total across 1 board, counting each seat separately. Longest: United Therapeutics Corporation, 2 years.
United Therapeutics Corporation
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 10, 2026 | United Therapeutics Corporation | Open-market sale | −325 | $550.59 | $178,942 |
| Jul 9, 2026 | United Therapeutics Corporation | Option exercise | +650 | — | — |
| Mar 17, 2026 | United Therapeutics Corporation | Open-market sale | −45 | $533.51 | $24,008 |
| Mar 3, 2026 | United Therapeutics Corporation | Open-market sale | −50 | $509.20 | $25,460 |
| Feb 17, 2026 | United Therapeutics Corporation | Open-market sale | −50 | $474.68 | $23,734 |
| Feb 3, 2026 | United Therapeutics Corporation | Open-market sale | −50 | $474.23 | $23,712 |
| Jan 16, 2026 | United Therapeutics Corporation | Open-market sale | −50 | $460.98 | $23,049 |
| Jan 5, 2026 | United Therapeutics Corporation | Open-market sale | −50 | $495.01 | $24,751 |
| Dec 23, 2025 | United Therapeutics Corporation | Open-market sale | −50 | $512.12 | $25,606 |
| Dec 11, 2025 | United Therapeutics Corporation | Open-market sale | −50 | $482.98 | $24,149 |
| Sep 9, 2025 | United Therapeutics Corporation | Open-market sale | −700 | $400.29 | $280,203 |
| Jul 25, 2025 | United Therapeutics Corporation | Option exercise | +590 | — | — |
| Jun 26, 2025 | United Therapeutics Corporation | Option exercise | +630 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.